These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23944651)

  • 21. Soluble Mediators in Platelet Concentrates Modulate Dendritic Cell Inflammatory Responses in an Experimental Model of Transfusion.
    Perros AJ; Christensen AM; Flower RL; Dean MM
    J Interferon Cytokine Res; 2015 Oct; 35(10):821-30. PubMed ID: 26133961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Random aggregates in newly produced platelet units are associated with platelet activation and release of the immunomodulatory factors sCD40L and RANTES.
    Sandgren P; Meinke S; Eckert E; Douagi I; Wikman A; Höglund P
    Transfusion; 2014 Mar; 54(3):602-12. PubMed ID: 23889505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The signaling role of CD40 ligand in platelet biology and in platelet component transfusion.
    Aloui C; Prigent A; Sut C; Tariket S; Hamzeh-Cognasse H; Pozzetto B; Richard Y; Cognasse F; Laradi S; Garraud O
    Int J Mol Sci; 2014 Dec; 15(12):22342-64. PubMed ID: 25479079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury.
    Khan SY; Kelher MR; Heal JM; Blumberg N; Boshkov LK; Phipps R; Gettings KF; McLaughlin NJ; Silliman CC
    Blood; 2006 Oct; 108(7):2455-62. PubMed ID: 16772606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble CD40 ligand impairs the anti-platelet function of peripheral blood angiogenic outgrowth cells via increased production of reactive oxygen species.
    Bou Khzam L; Hachem A; Zaid Y; Boulahya R; Mourad W; Merhi Y
    Thromb Haemost; 2013 May; 109(5):940-7. PubMed ID: 23426185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitation of coated platelet potential during collection, storage, and transfusion of apheresis platelets.
    Charania R; Smith J; Vesely SK; Dale GL; Holter J
    Transfusion; 2011 Dec; 51(12):2690-4. PubMed ID: 21645004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of platelet concentrates suspended in bicarbonated Ringer's solution in children who had platelet transfusion reactions.
    Kobayashi J; Yanagisawa R; Ono T; Tatsuzawa Y; Tokutake Y; Kubota N; Hidaka E; Sakashita K; Kojima S; Shimodaira S; Nakamura T
    Vox Sang; 2018 Feb; 113(2):128-135. PubMed ID: 29067694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The platelet as an immune cell-CD40 ligand and transfusion immunomodulation.
    Blumberg N; Spinelli SL; Francis CW; Taubman MB; Phipps RP
    Immunol Res; 2009 Dec; 45(2-3):251-60. PubMed ID: 19184537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components.
    Sigle JP; Infanti L; Studt JD; Martinez M; Stern M; Gratwohl A; Passweg J; Tichelli A; Buser AS
    Transfusion; 2013 Aug; 53(8):1788-97. PubMed ID: 23176347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion.
    Rasonglès P; Angelini-Tibert MF; Simon P; Currie C; Isola H; Kientz D; Slaedts M; Jacquet M; Sundin D; Lin L; Corash L; Cazenave JP
    Transfusion; 2009 Jun; 49(6):1083-91. PubMed ID: 19309473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysregulated pathways and differentially expressed proteins associated with adverse transfusion reactions in different types of platelet components.
    Aloui C; Barlier C; Awounou D; Thiam S; Fagan J; Claverol S; Tavernier E; Mounier C; Hamzeh-Cognasse H; Cognasse F; Garraud O; Laradi S
    J Proteomics; 2020 Apr; 218():103717. PubMed ID: 32088354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD40 ligand (CD154) involvement in platelet transfusion reactions.
    Sahler J; Spinelli S; Phipps R; Blumberg N
    Transfus Clin Biol; 2012 Jun; 19(3):98-103. PubMed ID: 22703674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged platelet storage associated with increased frequency of transfusion-related adverse events.
    Losos M; Biller E; Li J; Blower L; Hamad D; Patel G; Scrape S; Cataland S; Chen J
    Vox Sang; 2018 Feb; 113(2):170-176. PubMed ID: 29243264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the soluble proteins HMGB1, CD40L and CD62P during various platelet preparation processes and the storage of platelet concentrates: The BEST collaborative study.
    Cognasse F; Hamzeh Cognasse H; Eyraud MA; Prier A; Arthaud CA; Tiberghien P; Begue S; de Korte D; Gouwerok E; Greinacher A; Aurich K; Noorman F; Dumont L; Kelly K; Cloutier M; Bazin R; Cardigan R; Huish S; Smethurst P; Devine D; Schubert P; Johnson L; Marks DC;
    Transfusion; 2023 Jan; 63(1):217-228. PubMed ID: 36453841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling the effect of platelet concentrate supernatants on endothelial cells: focus on endocan/ESM-1.
    Tariket S; Sut C; Arthaud CA; Eyraud MA; Meneveaux A; Laradi S; Hamzeh-Cognasse H; Garraud O; Cognasse F
    Transfusion; 2018 Feb; 58(2):439-445. PubMed ID: 29238987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients.
    Fernández Bello I; Álvarez MT; López-Longo FJ; Arias-Salgado EG; Martín M; Jiménez-Yuste V; Rodríguez de la Rúa A; Butta NV
    Thromb Haemost; 2012 Jan; 107(1):88-98. PubMed ID: 22116092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutrophil CD40 enhances platelet-mediated inflammation.
    Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
    Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment.
    Osselaer JC; Messe N; Hervig T; Bueno J; Castro E; Espinosa A; Accorsi P; Junge K; Jacquet M; Flament J; Corash L
    Transfusion; 2008 Jun; 48(6):1061-71. PubMed ID: 18346019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage.
    Glenister KM; Payne KA; Sparrow RL
    Transfusion; 2008 Jan; 48(1):99-107. PubMed ID: 17894789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble CD40L release as test for functional platelet loss.
    Wenzel F; Hohlfeld T; Giers G
    Clin Lab; 2012; 58(3-4):337-42. PubMed ID: 22582510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.